Cargando…
Exacerbating Guillain–Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination
Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported. Exacerbation of Guillain–Barré syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. The patient is a 32-year-old male who dev...
Autor principal: | Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123983/ https://www.ncbi.nlm.nih.gov/pubmed/34055430 http://dx.doi.org/10.1155/2021/3619131 |
Ejemplares similares
-
Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2021) -
Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022) -
Guillain-Barre syndrome in 220 patients with COVID-19
por: Finsterer, Josef, et al.
Publicado: (2021) -
Guillain-Barré syndrome after COVID-19 vaccination
por: McKean, Norma, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)